Clinical Study

Two-Year Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome

Table 3

Two-year clinical outcomes.

Before PSMAfter PSM
LMCA (n = 155)Non-LMCA (n = 6274)p valueLMCA (n = 150)Non-LMCA (n = 150) value

All-cause death4 (2.6)82 (1.3)0.1533 (2.0)2 (1.3)1.000
Cardiac death4 (2.6)47 (0.7)0.0343 (2.0)0 (0)0.247
Myocardial infarction11 (7.1)116 (1.8)<0.00111 (3.0)2 (1.3)0.011
 Target vessel related8 (5.2)52 (0.8)<0.0018 (5.3)3 (2.0)0.125
 Target lesion related2 (1.3)31 (0.5)0.1882 (1.3)1 (0.7)1.000
Unplanned revascularization10 (6.5)546 (8.7)0.32510 (6.7)15 (10.0)0.296
 Target vessel related9 (5.8)146 (94.2)0.7229 (6.0)9 (6.0)1.000
 Target lesion related7 (4.5)148 (95.5)0.7557 (4.7)7 (4.7)1.000
In-stent thrombosis7 (4.5)51 (0.8)<0.0016 (4.0)2 (1.3)0.282
Stroke6 (3.9)88 (1.4)0.0255 (3.3)6 (4.0)0.759
Bleeding11 (7.1)401 (6.4)0.72311 (7.3)6 (4.0)0.212
MACCE24 (15.5)768 (12.2)0.22522 (14.7)23 (15.3)0.872

MACCE = major adverse cardiac and cerebrovascular events.